Search results
Results From The WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Portfolio company. A portfolio company (commonly abbreviated as PortCo) is a company or entity in which a venture capital firm, a startup studio, or a holding company invests. [1] All companies currently backed by a private equity firm can be spoken of as the firm's portfolio. [2]
Biotechnology is a multidisciplinary field that involves the integration of natural sciences and engineering sciences in order to achieve the application of organisms and parts thereof for products and services. [ 1] The term biotechnology was first used by Károly Ereky in 1919 [ 2] to refer to the production of products from raw materials ...
Biopharmaceutical. A biopharmaceutical, also known as a biological medical product, [ 1] or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, whole blood, blood components, allergenics, somatic cells ...
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and ...
Bioconvergence is a multidisciplinary approach in life sciences that leverages the integration of biotechnology, engineering, and computers to address complex challenges. This method aims to enhance diagnostic processes, develop advanced materials, and accelerate drug development. [1] In addition to healthcare, bioconvergence contributes to ...
The field of synthetic biology has not been good to investors. But maybe we've just been looking in the wrong places. 3 Companies That Don't Seem Like Synthetic Biology Stocks, but Actually Are
Nature Portfolio (formerly known as Nature Publishing Group and Nature Research) [1] is a division of the international scientific publishing company Springer Nature that publishes academic journals, magazines, online databases, and services in science and medicine.